Top compounds associated with response to ERVK3-1


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
mRNA indisulam CTRPv2 pan-cancer AAC 0.033 0.3
mRNA AZD8055 CTRPv2 pan-cancer AAC 0.036 0.3
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA SCH-529074 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA JW-480 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA GMX-1778 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA lapatinib CCLE pan-cancer AAC -0.043 0.3
mRNA istradefylline CTRPv2 pan-cancer AAC 0.056 0.3
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.038 0.3
Download CSV